European Pharmaceutical Association
GPTKB entity
Statements (67)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Association
|
| gptkbp:addresses |
Healthcare challenges
Drug shortages |
| gptkbp:advocatesFor |
Public health
Quality assurance Patient-centered care Intellectual property rights Sustainable development goals Access to medicines Diversity in clinical trials Transparency in pricing Sustainable healthcare |
| gptkbp:collaboratesWith |
gptkb:European_Union
Research institutions |
| gptkbp:contributedTo |
Policy development
|
| gptkbp:engagesIn |
International cooperation
Public-private partnerships Stakeholder engagement Regulatory affairs Public awareness campaigns Health technology assessment Advocacy efforts Health system strengthening. Pharmaceutical policy analysis |
| gptkbp:focusesOn |
Pharmaceutical industry
|
| gptkbp:founded |
2000
|
| gptkbp:hasMember |
National pharmaceutical associations
|
| gptkbp:headquarters |
gptkb:Brussels,_Belgium
|
| gptkbp:hosts |
Workshops
|
| https://www.w3.org/2000/01/rdf-schema#label |
European Pharmaceutical Association
|
| gptkbp:membership |
Pharmaceutical companies
|
| gptkbp:organizes |
Conferences
|
| gptkbp:participatesIn |
Public consultations
Global health initiatives Health policy discussions Pharmaceutical conferences |
| gptkbp:promotes |
Research and development
Health literacy Best practices Ethical standards Collaboration in research Patient engagement strategies Digital_health_solutions |
| gptkbp:provides |
Networking opportunities
Training programs Policy recommendations Technical assistance Guidance on regulations Information resources Crisis management resources Crisis response strategies Policy analysis tools |
| gptkbp:publishes |
Reports
|
| gptkbp:supports |
Clinical trials
Patient safety initiatives Innovation in pharmaceuticals Research funding initiatives Regulatory harmonization Pharmaceutical education Health equity initiatives Pharmaceutical supply chain integrity |
| gptkbp:worksOn |
Pharmaceutical waste management
Access to vaccines Pharmaceutical pricing issues |
| gptkbp:worksWith |
Stakeholders
Regulatory bodies Patient organizations |